-
Mashup Score: 13Timely Reporting of Patient-Reported Outcomes in Cancer Clinical Trials: An Ethical Imperative - 23 hour(s) ago
Cancer treatment often involves significant toxicity and interruptions to daily life. As a result, patient-reported outcomes (PROs) such as health-related quality of life (HRQoL) are an essential component of cancer research as they provide critical insights into the effects of therapies for patients beyond disease response and survival outcomes. Many clinical trials measure symptoms only (eg, pain) more so than a full suite of HRQoL domains. By contrast, HRQoL encompasses physical, psychological, and
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 67Financial Toxicity in Older Adults With Cancer and Their Caregivers | JCO Oncology Practice - 3 day(s) ago
With advances in cancer treatment, long-term survival rates have improved in recent decades, resulting in extended life expectancies for many patients. This progress brings substantial challenges, however, particularly in terms of the costs associated …#Financialtox in #gerionc: we discussed factors, interventions, knowledge gaps, and future research.
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Financial Toxicity in Older Adults With #Cancer and Their Caregivers. https://t.co/ddcqUlaLI5 @ASCO @JCO_ASCO @JCOOP_ASCO #FinancialToxicity #GeriOnc #PallOnc @MelissaLoh21 @CostsofCare @myCARG https://t.co/U2fcFS4FP5
-
-
Mashup Score: 19Primary Palliative Care for Emergency Medicine - 7 day(s) ago
This cluster randomized clinical trial compares the effect of a multicomponent intervention to initiate palliative care in the emergency department during a preintervention period vs a postintervention period on hospital admission, subsequent health care use, and survival in older adults with…
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
#Palliative Care Initiated in the Emergency Department: A Cluster Randomized Clinical Trial. https://t.co/vTSLvSUqyO @JAMA_current @JAMANetwork @JAMANetworkOpen #PalliativeCare #PallOnc #hpm @MSKCancerCenter https://t.co/mumcjSdESW
-
-
Mashup Score: 23The Price Is NOT Right: Payers’ Roles in Addressing Financial Toxicity | JCO Oncology Practice - 7 day(s) ago
From an economic perspective, one of the fundamental features of a well-designed insurance plan is financial protection against catastrophic loss. 1 Yet, while the United States has the most expensive health insurance in the world, 2 health insurance in the United States offers less financial protection against catastrophic loss than public or private insurance plans in other markets. 3 The experience of cancer and the cost of cancer care rise to the le vel of a catastrophic event, and thus, patients
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
The Price Is NOT Right: Payers’ Roles in Addressing Financial Toxicity. https://t.co/FNs8eXGxuv @ASCO @JCO_ASCO @JCOOP_ASCO #FinancialToxicity #CostsOfCare @manalipatelmd @CostsofCare https://t.co/j4HeNriW7o
-
-
Mashup Score: 8Participation in the Acute Hospital Care at Home Program - 9 day(s) ago
This cross-sectional study explores whether hospital participation in the Acute Hospital Care at Home program continued to increase following the extension of the program and the characteristics of participating hospitals.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
Hospital Participation in the Acute Hospital Care at Home Waiver Program. https://t.co/yIqnkIeLHJ @JAMA_current @JAMANetwork #HospitalAtHome https://t.co/GUSX4I7wYa
-
-
Mashup Score: 72Financial Toxicity in Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series | JCO Oncology Practice - 10 day(s) ago
The first academic article using the term “financial toxicity” was published in 2013, 1 which catalyzed the growth of an emerging field of research and quality improvement efforts focused on addressing patient affordability concerns. Although previous research had begun to describe the financial burden experienced by patients with cancer and the exorbitant costs of cancer care, the seminal article from Zafar et al and the subsequent editorials from experts we now recognize as leaders in this field
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Financial Toxicity in #Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series. https://t.co/yBjE56pPA7 @ASCO @JCO_ASCO @JCOOP_ASCO #FinancialToxicity #PallOnc #CostsOfCare #GeriOnc @fumikochino @EthicsdoctorP @yzafar @jamecancerdoc https://t.co/Fi6F1Czx8R
-
-
Mashup Score: 70Financial Toxicity in Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series | JCO Oncology Practice - 11 day(s) ago
The first academic article using the term “financial toxicity” was published in 2013, 1 which catalyzed the growth of an emerging field of research and quality improvement efforts focused on addressing patient affordability concerns. Although previous research had begun to describe the financial burden experienced by patients with cancer and the exorbitant costs of cancer care, the seminal article from Zafar et al and the subsequent editorials from experts we now recognize as leaders in this field
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Financial Toxicity in #Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series. https://t.co/yBjE56pPA7 @ASCO @JCO_ASCO @JCOOP_ASCO #FinancialToxicity #PallOnc #CostsOfCare #GeriOnc @fumikochino @EthicsdoctorP @yzafar @jamecancerdoc https://t.co/Fi6F1Czx8R
-
-
Mashup Score: 52Financial Toxicity in Older Adults With Cancer and Their Caregivers | JCO Oncology Practice - 11 day(s) ago
With advances in cancer treatment, long-term survival rates have improved in recent decades, resulting in extended life expectancies for many patients. This progress brings substantial challenges, however, particularly in terms of the costs associated …#Financialtox in #gerionc: we discussed factors, interventions, knowledge gaps, and future research.
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Financial Toxicity in Older Adults With #Cancer and Their Caregivers. https://t.co/ddcqUlaLI5 @ASCO @JCO_ASCO @JCOOP_ASCO #FinancialToxicity #GeriOnc #PallOnc @MelissaLoh21 @CostsofCare @myCARG https://t.co/U2fcFS4FP5
-
-
Mashup Score: 67Financial Toxicity in Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series | JCO Oncology Practice - 11 day(s) ago
The first academic article using the term “financial toxicity” was published in 2013, 1 which catalyzed the growth of an emerging field of research and quality improvement efforts focused on addressing patient affordability concerns. Although previous research had begun to describe the financial burden experienced by patients with cancer and the exorbitant costs of cancer care, the seminal article from Zafar et al and the subsequent editorials from experts we now recognize as leaders in this field
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Financial Toxicity in #Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series. https://t.co/yBjE56pPA7 @ASCO @JCO_ASCO @JCOOP_ASCO #FinancialToxicity #PallOnc #CostsOfCare #GeriOnc @fumikochino @EthicsdoctorP @yzafar @jamecancerdoc https://t.co/Fi6F1Czx8R
-
-
Mashup Score: 61Financial Toxicity in Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series | JCO Oncology Practice - 12 day(s) ago
The first academic article using the term “financial toxicity” was published in 2013, 1 which catalyzed the growth of an emerging field of research and quality improvement efforts focused on addressing patient affordability concerns. Although previous research had begun to describe the financial burden experienced by patients with cancer and the exorbitant costs of cancer care, the seminal article from Zafar et al and the subsequent editorials from experts we now recognize as leaders in this field
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Financial Toxicity in #Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series. https://t.co/yBjE56pPA7 @ASCO @JCO_ASCO @JCOOP_ASCO #FinancialToxicity #PallOnc #CostsOfCare #GeriOnc @fumikochino @EthicsdoctorP @yzafar @jamecancerdoc https://t.co/Fi6F1Czx8R
-
Timely Reporting of Patient-Reported Outcomes in #Cancer Clinical Trials: An Ethical Imperative. https://t.co/q7qxHVpZP5 @ASCO @JCO_ASCO @JCOOP_ASCO #PallOnc #SuppOnc #ClinicalTrials #CancerResearch https://t.co/gaiHRadS1V